Nicolas Soldermann

Biography

Nicolas Soldermann studied chemistry at Ecole Nationale Superieure de Chimie de Mulhouse where he obtained his Diplome d’Ingenieur Chimiste de l’Ecole Nationale Superieure de Chimie de Mulhouse, France, majoring in medicinal and bioorganic chemistry and a Master in Sciences in organic and macromolecular synthesis from the University of Haute-Alsace, France. He then moved in 1998 to Switzerland to the University of Neuchatel for a Ph.D. in organic chemistry with Prof. R. Neier. In 2002, he moved to Stanford University in the US for a Postdoc with Prof. P.A. Wender. Nicolas joined Novartis in 2003 in the Global Discovery Chemistry department as an investigator in medicinal chemistry and since then worked in Hit-to-Lead and Lead Optimization project for several diseases areas such as neurosciences, autoimmunity & transplantation and oncology. He led several projects from exploratory to late stage lead optimization yielding several clinical compounds including leniolisib currently in phase II for APDS. Nicolas spent about 10 years in the autoimmune and Transplantation field and since 2015 he is a Senior Investigator / chemistry group leader in Oncology and Immuno-Oncology.

Research Interest

 Microbiology